Airn E. Hartwig

IDEX Corporation (United States) — United States

Medicine · Health Sciences

17h-index1.3kcitations53works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(23), Animal Virus Infections Studies(15), Influenza Virus Research Studies(9), Viral Infections and Vectors(8), Mosquito-borne diseases and control(7)

Publications53 total

Pathogenesis and Transmissibility of Middle East Respiratory Syndrome Coronaviruses of African Origin in Alpacas
Viruses·2025Open Access
An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity
Journal of Controlled Release·2025· 3 citedOpen Access
A Highly Protective Clade 1 and 2 Cross-Reactive Pandemic Influenza Virus Vaccine Based on a 4th Generation Fully Deleted Adenoviral Vector of a Rare Serotype
2025Open Access
Postexposure Antimicrobial Drug Therapy in Goats Infected with <i>Burkholderia pseudomallei</i>
Emerging infectious diseases·2025Open Access
Development of an Intranasally- and Intramuscularly-Administrable Replicon Vaccine Efficacious Against H5N1 Influenza Virus
2025· 1 citedOpen Access
Intraspecific SARS-CoV-2 Delta variant transmission among red fox (Vulpes vulpes) and striped skunk (Mephitis mephitis)
Virology·2025· 1 cited
An intranasal, NLC-delivered self-amplifying RNA vaccine establishes protective immunity against pre-pandemic H5N1 and H7N9 influenza
2025· 4 citedOpen Access
Toxin and capsule production by Bacillus cereus biovar anthracis influence pathogenicity in macrophages and animal models
PLoS neglected tropical diseases·2024· 1 citedOpen Access
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses
2024· 4 citedOpen Access
Experimental SARS-CoV-2 Infection of Elk and Mule Deer
Emerging infectious diseases·2024· 13 citedOpen Access
Experimental infection of elk ( <i>Cervus canadensis</i> ) and mule deer ( <i>Odocoileus hemionus</i> ) with SARS-CoV-2
2023· 1 citedOpen Access
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
EBioMedicine·2023· 16 citedOpen Access
Disease Progression and Serological Assay Performance in Heritage Breed Pigs following Brucella suis Experimental Challenge as a Model for Naturally Infected Feral Swine
Pathogens·2023· 2 citedOpen Access
Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters
Microbiology Spectrum·2023· 7 citedOpen Access
Immunogenicity, Safety, and Anti-Viral Efficacy of a Subunit SARS-CoV-2 Vaccine Candidate in Captive Black-Footed Ferrets (Mustela nigripes) and Their Susceptibility to Viral Challenge
Viruses·2022· 3 citedOpen Access
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
2022· 1 citedOpen Access
Susceptibility of Wild Canids to SARS-CoV-2
Emerging infectious diseases·2022· 29 citedOpen Access
Susceptibility of wild canids to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2022· 9 citedOpen Access
American alligators are capable of West Nile virus amplification, mosquito infection and transmission
Virology·2022· 15 citedOpen Access
Activity of Galidesivir in a Hamster Model of SARS-CoV-2
Viruses·2021· 17 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Richard A. Bowen(38), Angela M. Bosco‐Lauth(24), Stephanie Porter(16), Helle Bielefeldt‐Ohmann(16), J. Jeffrey Root(9), Paul Gordy(7), Rachel M. Maison(6), Audrey Walker(5), Nicole L. Marlenee(5), G. Topolska(4), Alex D. Byas(3), Lauren Guilbert(3), Neal Van Hoeven(3), Christopher B. Fox(3), Danielle R. Adney(3), K. Krzyżańska(3), Matthew Ykema(3), Darshan N. Kasal(3), Madeleine F. Jennewein(3), Jasneet Singh(3)